2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
51
Disease
5
Obesity
2
Carcinoma, Intraductal, Noninfiltrating
2
Women With Breast Cancer
1
Prostatic Neoplasms
1
Obesity, Morbid
1
Neoplasms
1
Mammary Neoplasms, Animal
1
Hypersensitivity
1
Fibrocystic Breast Disease
1
Digital Breast Tomosynthesis
1
Cysts
1
Colorectal Neoplasms
1
Breast Screening
1
Breast Cancer Screening
1
Breast Cancer Detection
1
Asymptomatic
1
Acquired Immunodeficiency Syndrome
1
Interventions
Dexamethasone
3
iniparib
2
Ultrasonography
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Calcium Dobesilate
2
Blood Specimen Collection
2
tislelizumab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
asparaginase erwinia chrysanthemi recombinant
1
amminedichloro(2-methylpyridine)platinum(II)
1
ZD4054
1
Vincristine
1
Sodium Chloride
1
Rituximab
1
Paclitaxel
1
Narrow Band Imaging
1
Methotrexate
1
Mammography
1
Lenalidomide
1
Immune Checkpoint Inhibitors
1
High-Energy Shock Waves
1
Doxorubicin
1
Dexrazoxane
1
Cytarabine
1
Cetirizine
1
Carboplatin
1
BNT162 Vaccine
1
Asparaginase
1
2019-nCoV Vaccine mRNA-1273
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypersensitivity
×
Mammography
×
Clear all
NCT02909426
2021-10-07
MUST-BE
Soonchunhyang University Hospital
Unknown
11,880 enrolled